GSK Investigational Site — Memphis, Tennessee

GSK Investigational Site is a clinical research site located in Memphis, Tennessee, United States 38119.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

GSK Investigational Site has participated in 82 clinical trials with 1 currently active.

Therapeutic areas: Neoplasms, Prostate, Infection, Human Immunodeficiency Virus, Non-Small-Cell Lung Cancer.

Sponsors: GlaxoSmithKline, ViiV Healthcare, XenoPort, Inc..

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GSK Investigational Site?

GSK Investigational Site has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GSK Investigational Site conducted?

GSK Investigational Site has 82 clinical trials on record, with 1 currently active. Their work covers Neoplasms, Prostate, Infection, Human Immunodeficiency Virus, Non-Small-Cell Lung Cancer.

Is GSK Investigational Site accredited by Crixeo Health?

Yes — GSK Investigational Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about GSK Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.